Stanford researchers have developed a method using trained learning models to optimize synthetic DNA libraries for high-throughput molecular biology experiments.
Stanford inventors have developed a method to efficiently differentiate human pluripotent stem cells (hPSCs) into nearly pure populations of human blood progenitors or blood vessel cells in a Petri dish.
Stanford researchers in Prof. Corinne Beinat's lab have developed a small molecule radiotheranostic for targeted radionuclide therapy of cancers overexpressing system xc-, such as high-grade glioma and non-small cell lung cancer (NSCLC).
Stanford researchers in Prof. Engleman and Reticker-Flynn's labs have created a novel cell therapy that targets the T-antigen, a prominent tumor-specific antigen, by leveraging the high avidity interactions between lectins and glycans.
Undulator magnet cores are essential for advanced applications such as synchrotron radiation sources, advanced chip manufacturing, and fusion technology. SLAC researchers have a new manufacturing approach that achieves greater precision at significantly lower costs.
Stanford researchers have developed ModulADAR - a novel RNA sensing platform that enables precise, cell-type or state-specific activation of mRNA expression using ADAR editing, offering unparalleled flexibility and specificity for targeted RNA therapeutics.
Hydrogen that is free of greenhouse gas (GHG) emissions is a key vector to fuel a net-zero emissions economy, but today's H2 is sourced from fossil fuels mostly by the highly emissions-intensive processes of steam methane reforming (SMR) or coal gasification.
Stanford University and University of Wisconsin–Madison researchers have developed a new device to achieve upconversion (UC) of incoherent near-infrared (NIR) photons beyond 1100nm to visible photons, through sensitized triplet–triplet annihilation (TTA).
Overweight and obesity are linked to an increased risk and worsened outcome from many cancers, including colorectal, pancreatic and breast cancer, but the mechanisms responsible for these phenomena are unknown.
Stanford researchers have defined subgroups of regulatory T cell (Tregs), CD39+ and CD39-, that can be genetically engineered to produce enhanced or reduced cytotoxicity without affecting their ability to suppress the immune system.
Scientists in the Carette Lab at Stanford have developed AAV-Titer cell lines that enable (1) improved and standardized in vitro potency assays (2) determination of a functional titer of AAV vectors of different serotypes and containing different promotors.
Stanford researchers have developed a novel methodology for the high-throughput expression and kinetic characterization of numerous enzyme variants in parallel using microfluidic droplet arrays.
The recognition of peptide-MHC (pMHC) complexes by T cells is the cornerstone of cellular immunity, enabling the elimination of infected or tumoral cells. pMHC can thus be leveraged as a detection tool for T cells.
Stanford researchers have developed a 3D-printed biodegradable zinc implant with mechanical properties suitable for structural support after core decompression in osteonecrosis patients.